Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc ICOTF


Primary Symbol: T.MSCL Alternate Symbol(s):  MSCLF

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).


TSX:MSCL - Post by User

Post by blinkieon Jan 19, 2021 7:19pm
297 Views
Post# 32330172

The Manipulation Contunues @ $0.01 Higher

The Manipulation Contunues @ $0.01 HigherAccusation. accumulation. Accumulation.

This definitely happening.  It occurred as the stock fluctuated between $0.05 -$0.55. Turning over millions of shares @ $0.05 & then moving it up to $0.055.

Classic examples of market manipulation taking out all the smaller and impatient little guys.

Obviously those in the $0.05's are gone.

Next a large turnover @ the $0.065 (over B6 Million+) virtually eliminating those buyers at $0.4 -$0.55.  Again the smaller & impatient lose out again.

The real breakout is close.  The big guys will scare some of the shareholders by manipulating (short term) shareholders @ $0.055 - $0.6 who get nervous & sell.  BUT the big boys will not take the risk that News might come out and they recover/maintain their positions @ $0.065.

Soon those who bought at the $0.05 level may sell at &0.07.

Soon ...very soon.. the anticipated News will come out & there will be vet few shares available & the SP will take off.

I say Bring On The News !,  This is going to be exciting.

With accumulations of over 30 Million shares since mid December we will see a much higher price.


<< Previous
Bullboard Posts
Next >>